U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H21NO
Molecular Weight 219.3226
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-((1-PHENYLCYCLOHEXYL)AMINO)ETHANOL

SMILES

OCCNC1(CCCCC1)C2=CC=CC=C2

InChI

InChIKey=KPRIKYIJCZVTDK-UHFFFAOYSA-N
InChI=1S/C14H21NO/c16-12-11-15-14(9-5-2-6-10-14)13-7-3-1-4-8-13/h1,3-4,7-8,15-16H,2,5-6,9-12H2

HIDE SMILES / InChI

Molecular Formula C14H21NO
Molecular Weight 219.3226
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sun Dec 18 16:52:46 UTC 2022
Edited
by admin
on Sun Dec 18 16:52:46 UTC 2022
Record UNII
UDC7319AKX
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2-((1-PHENYLCYCLOHEXYL)AMINO)ETHANOL
Systematic Name English
ETHANOL, 2-((1-PHENYLCYCLOHEXYL)AMINO)-
Systematic Name English
Code System Code Type Description
CAS
2201-22-1
Created by admin on Sun Dec 18 16:52:46 UTC 2022 , Edited by admin on Sun Dec 18 16:52:46 UTC 2022
PRIMARY
FDA UNII
UDC7319AKX
Created by admin on Sun Dec 18 16:52:46 UTC 2022 , Edited by admin on Sun Dec 18 16:52:46 UTC 2022
PRIMARY
PUBCHEM
91394879
Created by admin on Sun Dec 18 16:52:46 UTC 2022 , Edited by admin on Sun Dec 18 16:52:46 UTC 2022
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
This metabolite was detected in rat urine. However, according to this journal acticle, “The authors' experience in metabolism and analytical studies on rats and humans support the assumption that the metabolites found in rat urine should also be present in human urine. Therefore, it can be concluded that the procedure described here should also be applicable for human urine screening for PCEEA and/or PCMEA in clinical or forensic cases. However, their differentiation would only be possible through detection of the respective parent drug or unique metabolites.”
URINE
PARENT -> METABOLITE
This metabolite was detected in rat urine. However, according to the journal acticle, “The authors' experience in metabolism and analytical studies on rats and humans support the assumption that the metabolites found in rat urine should also be present in human urine. Therefore, it can be concluded that the procedure described here should also be applicable for human urine screening for PCEEA and/or PCMEA in clinical or forensic cases. However, their differentiation would only be possible through detection of the respective parent drug or unique metabolites.”
URINE